Copyright © 2005, European Society of Cardiology
Delivery of Chlamydia pneumoniae to the vessel wall aggravates atherosclerosis in LDLr-/- mice
aDivision of Biopharmaceutics, Leiden University, Leiden, The Netherlands
bDepartment of Internal Medicine, Academic Hospital Maastricht, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands
cDepartment of Medical Microbiology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands
* Corresponding author. LACDR, Div. of Biopharmaceutics, Gorlaeus Laboratories, Einsteinweg 55, 2333 CC Leiden, PO Box 9502, 2300 RA Leiden, The Netherlands. Tel.: +31 71 5276051; fax: +31 71 5276032. Email address: a.hauer{at}lacdr.leidenuniv.nl
Objective: The role of Chlamydia pneumoniae in atherosclerosis is still debated. In this study a novel mouse model was applied to determine the direct impact of C. pneumoniae on the arterial wall and the development of atherosclerosis.
Methods: Direct effects of C. pneumoniae on collar-induced atherosclerosis were studied after local delivery of C. pneumoniae to carotid arteries of LDL receptor-deficient (LDLr-/-) mice.
Results: The presence of C. pneumoniae in the vessel wall was quantified by RT-PCR (6.2 x 104 copies/artery) and resulted in a 2.0-fold increase in intima/media ratios (p<0.05) and a 1.7-fold increase in stenosis (p<0.05). Immunostaining revealed a 2.98-fold (p<0.01) increased macrophage content and a tendency towards lower numbers of smooth muscle cells and collagen in lesions of infected carotid arteries. Direct delivery of another respiratory pathogen, Mycoplasma pneumoniae, to the carotids did not affect size or composition of the atherosclerotic lesions. Presence of C. pneumoniae in the carotid arteries resulted within 7 days in a marked upregulation of the expression of MCP-1 (p<0.01) and ICAM-1 as determined on mRNA and protein levels. These in vivo data were in line with data obtained with in vitro infections of macrophages and endothelial cells with C. pneumoniae.
Conclusions: We conclude that C. pneumoniae in carotid arteries leads to more pronounced atherosclerotic lesions with a more vulnerable morphology and that this model is suitable to monitor direct effects of C. pneumoniae on atherogenesis.
KEYWORDS Chlamydia pneumoniae; Atherosclerosis; Inflammation; Mouse model
Time for primary review 36 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Chen, H. Chai, X. Wang, P. H. Lin, and Q. Yao Chlamydia heat shock protein 60 decreases expression of endothelial nitric oxide synthase in human and porcine coronary artery endothelial cells Cardiovasc Res, June 4, 2009; (2009) cvp150v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. K. Curtiss and P. S. Tobias Emerging role of Toll-like receptors in atherosclerosis J. Lipid Res., April 1, 2009; 50(Supplement): S340 - S345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Jaff, R. A. Dale, M. A. Creager, R. J. Lipicky, J. Constant, L. A. Campbell, and W. R. Hiatt Anti-Chlamydial Antibiotic Therapy for Symptom Improvement in Peripheral Artery Disease: Prospective Evaluation of Rifalazil Effect on Vascular Symptoms of Intermittent Claudication and Other Endpoints in Chlamydia pneumoniae Seropositive Patients (PROVIDENCE-1) Circulation, January 27, 2009; 119(3): 452 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Naiki, R. Sorrentino, M. H. Wong, K. S. Michelsen, K. Shimada, S. Chen, A. Yilmaz, A. Slepenkin, N. W. J. Schroder, T. R. Crother, et al. TLR/MyD88 and Liver X Receptor {alpha} Signaling Pathways Reciprocally Control Chlamydia pneumoniae-Induced Acceleration of Atherosclerosis J. Immunol., November 15, 2008; 181(10): 7176 - 7185. [Abstract] [Full Text] [PDF]
|
|